142 related articles for article (PubMed ID: 29781588)
1. Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study.
Jaeger VK; Valentini G; Hachulla E; Cozzi F; Distler O; Airó P; Czirják L; Allanore Y; Siegert E; Rosato E; Matucci-Cerinic M; Caimmi C; Henes J; Carreira PE; Smith V; Del Galdo F; Denton CP; Ullman S; De Langhe E; Riccieri V; Alegre-Sancho JJ; Rednic S; Müller-Ladner U; Walker UA;
Arthritis Rheumatol; 2018 Nov; 70(11):1829-1834. PubMed ID: 29781588
[TBL] [Abstract][Full Text] [Related]
2. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group.
Jordan S; Distler JH; Maurer B; Huscher D; van Laar JM; Allanore Y; Distler O;
Ann Rheum Dis; 2015 Jun; 74(6):1188-94. PubMed ID: 24442885
[TBL] [Abstract][Full Text] [Related]
3. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
[TBL] [Abstract][Full Text] [Related]
4. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
Burt RK; Shah SJ; Dill K; Grant T; Gheorghiade M; Schroeder J; Craig R; Hirano I; Marshall K; Ruderman E; Jovanovic B; Milanetti F; Jain S; Boyce K; Morgan A; Carr J; Barr W
Lancet; 2011 Aug; 378(9790):498-506. PubMed ID: 21777972
[TBL] [Abstract][Full Text] [Related]
5. Interrelationships between pulmonary and extrapulmonary involvement in systemic sclerosis. A longitudinal analysis.
Tashkin DP; Clements PJ; Wright RS; Gong H; Simmons MS; Lachenbruch PA; Furst DE
Chest; 1994 Feb; 105(2):489-95. PubMed ID: 8306752
[TBL] [Abstract][Full Text] [Related]
6. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database.
Wirz EG; Jaeger VK; Allanore Y; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Tikly M; Vettori S; Balbir Gurman A; Damjanov N; Müller-Ladner U; Distler J; Li M; Häusermann P; Walker UA;
Ann Rheum Dis; 2016 Jul; 75(7):1285-92. PubMed ID: 26232495
[TBL] [Abstract][Full Text] [Related]
7. Cigarette Smoke Exposure and Radiographic Pulmonary Vascular Morphology in the Framingham Heart Study.
Synn AJ; Zhang C; Washko GR; Estépar RSJ; O'Connor GT; Li W; Mittleman MA; Rice MB
Ann Am Thorac Soc; 2019 Jun; 16(6):698-706. PubMed ID: 30714821
[No Abstract] [Full Text] [Related]
8. Do We Have Good Activity Indices in Systemic Sclerosis?
Groseanu L; Petrescu S; Balanescu A; Bojinca V; Opris-Belinski D; Berghea F; Mazilu D; Saulescu I; Borangiu A; Daia-Iliescu S; Constantinescu C; Cobilinschi C; Abobului M; Negru MM; Ionescu R
Curr Rheumatol Rev; 2022; 18(1):39-47. PubMed ID: 34517805
[TBL] [Abstract][Full Text] [Related]
9. Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis.
Yayla ME; İlgen U; Okatan İE; UsluYurteri E; Torgutalp M; Keleşoğlu Dinçer AB; Aydemir Gülöksüz EG; Sezer S; Turgay TM; Kınıklı G; Ateş A
Clin Rheumatol; 2020 Jan; 39(1):77-83. PubMed ID: 31317426
[TBL] [Abstract][Full Text] [Related]
10. The clinical value of the delta finger to palm distance in systemic sclerosis.
Javinani A; Mostafaei S; Gharibdoost F; Jamshidi AR; Atef Yekta R; Kiani Fard T; Tamartash Z; Gorgani F; Mirbeyk M; Mahmoudi M; Sadeghi K; Kavosi H
Reumatismo; 2020 Apr; 72(1):44-51. PubMed ID: 32292020
[TBL] [Abstract][Full Text] [Related]
11. Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis.
Nevskaya T; Zheng B; Baxter CA; Ramey DR; Pope JE; Baron M;
Rheumatology (Oxford); 2020 Jul; 59(7):1715-1724. PubMed ID: 31774531
[TBL] [Abstract][Full Text] [Related]
12. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort.
Wu W; Jordan S; Graf N; de Oliveira Pena J; Curram J; Allanore Y; Matucci-Cerinic M; Pope JE; Denton CP; Khanna D; Distler O;
Ann Rheum Dis; 2019 May; 78(5):648-656. PubMed ID: 30852552
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort.
Nevskaya T; Baron M; Pope JE;
Rheumatology (Oxford); 2017 Jul; 56(7):1111-1122. PubMed ID: 28340090
[TBL] [Abstract][Full Text] [Related]
14. Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study.
Matsuda KM; Yoshizaki A; Kuzumi A; Fukasawa T; Ebata S; Miura S; Toyama T; Yoshizaki A; Sumida H; Asano Y; Oba K; Sato S
Arthritis Res Ther; 2019 May; 21(1):129. PubMed ID: 31138286
[TBL] [Abstract][Full Text] [Related]
15. Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort.
Ciaffi J; Liem SIE; Cannegieter S; Ahmed S; Hoekstra EM; Wiland P; Atsumi T; Szücs G; Balbir Gurman A; Czirják L; Zanatta E; Koetter I; Henes JC; Matucci-Cerinic M; Airò P; Ursini F; Huizinga TWJ; De Vries-Bouwstra J; Collaborators E
RMD Open; 2024 May; 10(2):. PubMed ID: 38772679
[TBL] [Abstract][Full Text] [Related]
16. Does cigarette smoking mitigate the severity of skin disease in systemic sclerosis?
Gyger G; Hudson M; Lo E; Steele R; ; Baron M
Rheumatol Int; 2013 Apr; 33(4):943-8. PubMed ID: 22829414
[TBL] [Abstract][Full Text] [Related]
17. Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis.
Peters-Golden M; Wise RA; Schneider P; Hochberg M; Stevens MB; Wigley F
Medicine (Baltimore); 1984 Jul; 63(4):221-31. PubMed ID: 6738343
[TBL] [Abstract][Full Text] [Related]
18. The Modified Hand Mobility in Scleroderma Test and Skin Involvement - A Followup Study.
Sandqvist G; Wuttge DM; Hesselstrand R
J Rheumatol; 2016 Jul; 43(7):1356-62. PubMed ID: 27134250
[TBL] [Abstract][Full Text] [Related]
19. Decline in FEV
Hiller AM; Piitulainen E; Jehpsson L; Tanash H
Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
[No Abstract] [Full Text] [Related]
20. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
